Navigation Links
Patients who refuse prostate cancer surgery have worse long-term survival
Date:6/1/2010

DETROIT Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" monitoring cancer progression without undergoing treatment have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.

The study found that patients who refused any treatment for their prostate cancer had a 10-year overall survival rate of 51 percent, compared to 68 percent for those who chose radiation treatment.

"Surgery has been shown to offer a survival advantage to patients with prostate cancer when compared with other treatment options. However, a significant number of patients refuse surgery and instead opt for other treatments such as radiotherapy" says study lead author Naveen Pokala, M.D., an urologist at Henry Ford Hospital.

The study was presented at the 2010 American Urology Association's annual meeting in San Francisco.

These findings follow a study published by Dr. Pokala in 2009 that showed surgery improves 5-, 10- and 15-year survival rates for men younger than 50 with moderately and especially in poorly differentiated prostate cancers, when compared with other standard treatments such as radiation therapy or watchful waiting.

The new research, a population-based analysis of 9,704 patients chosen from the National SEER database, looked at survival rates among men with a mean age of 64.4 years, of whom 77 percent were white and 16.4 percent black.

Of that group, nearly 30 percent refused any treatment for their prostate cancers, and about 70 percent chose radiation therapy.

Within the group, 6 percent had well-differentiated cancers, 75 percent moderately differentiated cancers, and 18 percent had poorly differentiated cancer.

More than 70 percent of the patients were unmarried. In all, African American men older than 65 had the worst prognosis.

Prostate cancer is second only to skin cancer as the most common cancer in American men, affecting one in six during his lifetime. The majority of the cases are in men older than 65, but it is becoming more prevalent in men under 40.

It affects black men twice as often as whites, and their mortality rate is also twice as high.

While curable in its early stages, symptoms often don't appear until the cancer has spread beyond the prostate gland itself, so annual exams for the disease are recommended.


'/>"/>

Contact: Krista Hopson
khopson1@hfhs.org
313-874-7207
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Lack of private insurance contribute to higher deaths among black heart transplant patients
2. Comparision of overall survival for non-small cell lung cancer patients
3. Response to preoperative therapy may predict survival in pancreatic cancer patients
4. Circulating tumor cells correlate with poorer survival in pancreatic cancer patients
5. Ultrasound Helps Spot Stroke Risk in Symptomless Patients
6. Too Many Stroke Patients Go Without Statins
7. Exercise Boosts Health of Cancer Patients
8. As Popularity of Dental Implants Rise, a Chicago Cosmetic Dentistry Practice's On-site Lab Offers Patients a Unique Incentive
9. Proton Therapy Carries Precise, Potent Punch Against Cancers for Patients at The Children's Hospital of Philadelphia
10. Mayo Clinic Proceedings: Review of pain management practices for cirrhosis patients
11. New Medic Monthly Course Focuses on DNR Orders for Patients with Terminal Illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: